Decheng Capital Management III (Cayman)’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
$42.1M Hold
2,099,583
14.06% 2
2023
Q2
$59.2M Buy
2,099,583
+275,000
+15% +$7.76M 18.58% 2
2023
Q1
$31.4M Hold
1,824,583
12.66% 2
2022
Q4
$36.7M Hold
1,824,583
13.75% 2
2022
Q3
$39.5M Hold
1,824,583
14.33% 2
2022
Q2
$51.3M Buy
+1,824,583
New +$51.3M 19.44% 1